Use of Nanotechnology in Diagnosis and Treatment of Hepatic Fibrosis: A Review

(2016) Use of Nanotechnology in Diagnosis and Treatment of Hepatic Fibrosis: A Review. Current Drug Delivery. pp. 662-672. ISSN 1567-2018

Full text not available from this repository.

Abstract

Liver fibrosis is an important cause of morbidity and mortality worldwide and represent a difficult clinical challenge of global importance. The liver fibrosis progression needs to be controlled because persisted liver fibrosis can lead to liver cirrhosis or even hepatocellular carcinoma. Despite significant advances in the understanding of the liver fibrosis development, the therapeutic effect of drugs used in liver fibrosis treatment is not sufficient. Today, nanotechnology has been considered as a potential tool for developing novel drug delivery systems for the improved imaging and various diseases, including liver fibrosis. In this article, we discussed the use of nanotechnology for the treatment and imaging of liver fibrosis.

Item Type: Article
Keywords: antifibrotic therapy antiviral therapy hepatic stellate cells liver fibrosis nanotechnology sirna superparamagnetic iron-oxide drug-delivery systems salvianolic acid-b liver fibrosis stellate cells in-vivo targeted delivery oral bioavailability silica nanoparticles stimulator substance
Page Range: pp. 662-672
Journal or Publication Title: Current Drug Delivery
Journal Index: ISI
Volume: 13
Number: 5
Identification Number: https://doi.org/10.2174/1567201812666150907115404
ISSN: 1567-2018
Depositing User: مهندس مهدی شریفی
URI: http://eprints.mui.ac.ir/id/eprint/3052

Actions (login required)

View Item View Item